Alpha 2.0
Login Register
» Articles » PMID: 38854627

Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis

Overview
Journal Blood Lymphat Cancer
Publisher Dove Medical Press
Specialty Hematology
Date 2024 Jun 10
PMID 38854627
Authors
Nan Mei
Sha Gong
Lizhao Wang
Lu Wang
Jincheng Wang
Jianpeng Li
Yingying Bao
Huanming Zhang
Huaiyu Wang
Affiliations
Soon will be listed here.
Abstract

Background: Multiple myeloma (MM), an incurable plasma cell malignancy. The significance of the relationship between natural killer (NK) cell-related genes and clinical factors in MM remains unclear.

Methods: Initially, we extracted NK cell-related genes from peripheral blood mononuclear cells (PBMC) of healthy donors and MM samples by employing single-cell transcriptome data analysis in TISCH2. Subsequently, we screened NK cell-related genes with prognostic significance through univariate Cox regression analysis and protein-protein interaction (PPI) network analysis. Following the initial analyses, we developed potential subtypes and prognostic models for MM using consensus clustering and lasso regression analysis. Additionally, we conducted a correlation analysis to explore the relationship between clinical features and risk scores. Finally, we constructed a weighted gene co-expression network analysis (WGCNA) and identified differentially expressed genes (DEGs) within the MM cohort.

Results: We discovered that 153 NK cell-related genes were significantly associated with the prognosisof MM patients ( <0.05). Patients in NK cluster A exhibited poorer survival outcomes compared to those in cluster B. Furthermore, our NK cell-related genes risk model revealed that patients with a high risk score had significantly worse prognoses ( <0.05). Patients with a high risk score were more likely to exhibit adverse clinical markers. Additionally, the nomogram based on NK cell-related genes demonstrated strong prognostic performance. The enrichment analysis indicated that immune-related pathways were significantly correlated with both the NK subtypes and the NK cell-related genes risk model. Ultimately, through the combined use of WGCNA and DEGs analysis, and by employing Venn diagrams, we determined that ITM2C is an independent prognostic marker for MM patients.

Conclusion: In this study, we developed a novel model based on NK cell-related genes to stratify the prognosis of MM patients. Notably, higher expression levels of ITM2C were associated with more favorable survival outcomes in these patients.

References
1.
Shu L, Tang J, Liu S, Tao Y . Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma. Cell Oncol (Dordr). 2023; 47(2):555-571. DOI: 10.1007/s13402-023-00883-w. View
2.
Bai L, You Q, Feng X, Kovach A, Li H . Structure of the ER membrane complex, a transmembrane-domain insertase. Nature. 2020; 584(7821):475-478. PMC: 7442705. DOI: 10.1038/s41586-020-2389-3. View
3.
Quach H, Ritchie D, Stewart A, Neeson P, Harrison S, Smyth M . Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia. 2009; 24(1):22-32. PMC: 3922408. DOI: 10.1038/leu.2009.236. View
4.
Wang D, Uyemura B, Hashemi E, Bjorgaard S, Riese M, Verbsky J . Role of GATA2 in Human NK Cell Development. Crit Rev Immunol. 2021; 41(2):21-33. PMC: 11536496. DOI: 10.1615/CritRevImmunol.2021037643. View
5.
Xiao B, Hang J, Lei T, He Y, Kuang Z, Wang L . Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system. Mol Biol Rep. 2019; 46(2):2111-2119. DOI: 10.1007/s11033-019-04663-4. View